| Literature DB >> 34198944 |
Alex N Manin1, Ksenia V Drozd1, Alexander P Voronin1, Andrei V Churakov2, German L Perlovich1.
Abstract
Single crystal of furazolidone (FZL) has been successfully obtained, and its crystal structure has been determined. Common and distinctive features of furazolidone and nitrofurantoin (NFT) crystal packing have been discussed. Combined use of QTAIMC and Hirshfeld surface analysis allowed characterizing the non-covalent interactions in both crystals. Thermophysical characteristics and decomposition of NFT and FZL have been studied by differential scanning calorimetry (DSC), thermogravimetric analysis (TG) and mass-spectrometry. The saturated vapor pressures of the compounds have been measured using the transpiration method, and the standard thermodynamic functions of sublimation were calculated. It was revealed that the sublimation enthalpy and Gibbs energy of NFT are both higher than those for FZL, but a gain in the crystal lattice energy of NFT is leveled by an entropy increase. The solubility processes of the studied compounds in buffer solutions with pH 2.0, 7.4 and in 1-octanol was investigated at four temperatures from 298.15 to 313.15 K by the saturation shake-flask method. The thermodynamic functions of the dissolution and solvation processes of the studied compounds have been calculated based on the experimental data. Due to the fact that NFT is unstable in buffer solutions and undergoes a solution-mediated transformation from an anhydrate form to monohydrate in the solid state, the thermophysical characteristics and dissolution thermodynamics of the monohydrate were also investigated. It was demonstrated that a combination of experimental and theoretical methods allows performing an in-depth study of the relationships between the molecular and crystal structure and pharmaceutically relevant properties of nitrofuran antibiotics.Entities:
Keywords: crystal lattice energy; crystal structure; furazolidone; nitrofurantoin; solubility; sublimation thermodynamics; transpiration method
Mesh:
Substances:
Year: 2021 PMID: 34198944 PMCID: PMC8201255 DOI: 10.3390/molecules26113444
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of nitrofurantoin and furazolidone.
Crystallography parameters of FZL.
| Empirical Formula | C8H7N3O5 |
|---|---|
| Formula weight | 225.17 |
| Crystal system | Orthorhombic |
| Space group | |
| 22.7977(13) | |
| 6.2422(3) | |
| 6.5085(5) | |
| Unit cell volume (Å3) | 926.21(10) |
|
| 4 |
| Calc. density (g·cm−3) | 1.615 |
| Absorption coefficient (mm−1) | 0.137 |
| 1.79–26.00 | |
| No. of measured, independent ( | 3737, 988 (0.069), 816 |
| Final | |
| Final | |
| Goodness of fit | 1.039 |
| max/min Δρ (e·Å−3) | 0.188/−0.245 |
Figure 2(a) ORTEP illustration of an asymmetric unit of the FZL crystal, showing the atom-labelling scheme. Thermal ellipsoids are drawn at the 50% probability level; (b) a 2D layer of FZL molecules formed by C−H···O bonds (green dots) and weak interactions; (c) packing of 2D layers in the crystal. The numbers indicate the energy of H-bonds estimated using Equation (11) in kJ·mol−1.
Contributions of different types of stabilizing non-covalent interactions into the lattice energy of NFT and FZL in kJ·mol−1 and % of the Elatt(0K) value (in brackets).
| NFT | FZL | |
|---|---|---|
| 139.6 | 121.9 | |
| Molecules in chain | 33.8 (24.2%) | 28.5 (23.4%) |
| Chains in layer | 40.7 (29.2%) | 18.6 (15.3%) |
| Layers in crystal | 65.2 (46.7%) | 74.8 (61.3%) |
| 27.9 (20.0%) | 0 (0%) | |
| Σ | 52.9 (37.9%) | 55.4 (45.4%) |
| Σ | 58.8 (42.1%) | 60.0 (49.2%) |
| Σ | 0 (0%) | 6.6 (5.4%) |
Figure 3Results of the Hirshfeld surface analysis of NFT and FZL crystals.
Figure 4DSC (black) and TG (blue) curves of (a) NFT and (b) FZL.
Figure 5Plots of vapor pressure against reciprocal temperature of the compounds studied.
Sublimation thermodynamic parameters of the investigated compounds.
| NFT | FZL | |
|---|---|---|
| 1.19·10−10 | 1.12·10−8 | |
| 85.2 | 74.1 | |
| 139.9 ± 0.7 | 122.0 ± 1.1 | |
| a | 287.8 | 286.4 |
| 146.5 ± 0.7 | 127.9 ± 1.1 | |
| 205.5 ± 2.8 | 180.6 ± 4.6 | |
| 61.3 | 53.9 | |
| b | 70.5 | 70.4 |
| b | 29.5 | 29.6 |
| c | 36.3 | 37.5 |
a was calculated according to Chickos’ additive scheme [25]. b . . c β = V/V.
Figure 6(a) Correlation between melting temperature and sublimation Gibbs energy; (b) Gibbs energy and enthalpy of sublimation for the set of compounds. The red circles represent results for the studied compounds.
Temperature dependences of solubility (X, mol. frac. and S, mol·L−1) of NFT and FZL in buffer solutions (pH 2.0 and 7.4), 1-octanol at pressure p = 0.1 MPa.
| Compound | T, K | Buffer pH 2.0 | Buffer pH 7.4 | 1-octanol |
|---|---|---|---|---|
| NFT | 298.15 | 1.49 (0.83) | 3.28 (1.82) | 3.61 (2.30) |
| 303.15 | 1.82 (1.01) | 4.33 (2.40) | 4.97 (3.17) | |
| 308.15 | 2.26 (1.25) | 5.51(3.06) | 6.53 (4.16) | |
| 313.15 | 2.46 (1.37) | 6.72(3.73) | 8.26 (5.26) | |
| [NFT + H2O] | 298.15 | 0.73 (0.40) | 1.49 (0.83) | - |
| 303.15 | 1.07 (0.59) | 2.34 (1.30) | - | |
| 308.15 | 1.43 (0.79) | 3.83 (2.13) | - | |
| 313.15 | 1.96 (1.08) | 5.90 (3.28) | - | |
| FZL | 298.15 | 3.35 (1.86) | 3.31 (1.84) | 1.13 (0.72) |
| 303.15 | 4.28 (2.38) | 4.27 (2.37) | 1.70 (1.09) | |
| 308.15 | 5.40 (3.00) | 5.43 (3.02) | 2.12 (1.59) | |
| 313.15 | 7.62 (4.23) | 7.65 (4.25) | 2.76 (2.24) |
Figure 7Effect of temperature on the dissolution profiles of the anhydrate NFT in buffer solutions (a) pH 2.0 and (b) pH 7.4. (–■– 298.15 K; –■– 303.15 K; –■– 308.15 K; –■– 313.15 K).
Thermodynamic functions of solubility and solvation processes of NFT and FZL in solvents studied at 298.15 K.
| Solvent |
|
|
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||
| pH 2.0 | 1.49·105 | 27.5 | 26.6 ± 2.8 | −0.9 | −3.1 ± 3.7 | −57.7 | −119.9 | −62.2 | −208.6 | 65.8 | 34.2 |
| pH 7.4 | 3.28·105 | 25.6 | 37.5 ± 1.9 | 11.9 | 39.9 ± 2.7 | −59.6 | −109.0 | −49.4 | −165.6 | 68.8 | 31.2 |
| 1-octanol | 3.61·105 | 25.4 | 42.8 ± 1.7 | 17.5 | 58.5 ± 2.5 | −59.8 | −103.7 | −43.8 | −147.0 | 70.3 | 29.7 |
|
| |||||||||||
| pH 2.0 | 0.73·105 | 29.3 | 50.5 ± 1.7 | 21.1 | 70.9 ± 2.6 | - | - | - | - | - | - |
| pH 7.4 | 1.98·105 | 26.8 | 71.8 ± 1.2 | 44.3 | 148.5 ± 2.0 | - | - | - | - | - | - |
|
| |||||||||||
| pH 2.0 | 3.35·106 | 31.3 | 41.8 ± 3.2 | 10.5 | 35.4 ± 4.0 | −42.8 | −86.1 | −43.3 | −145.2 | 66.5 | 33.5 |
| pH 7.4 | 3.31·106 | 31.3 | 42.8 ± 2.8 | 11.5 | 38.4 ± 4.0 | −42.8 | −85.1 | −42.4 | −142.2 | 66.7 | 33.3 |
| 1-octanol | 1.13·105 | 27.7 | 49.4 ± 4.4 | 21.7 | 72.6 ± 5.2 | −46.4 | −78.5 | −32.2 | −108.0 | 70.9 | 29.1 |
|
| |||||||||||
List of chemicals used in this study.
| Compound | CAS Register No. | Source | Mass Fraction Purity * |
|---|---|---|---|
| Nitrofurantoin | 67-20-9 | Sigma-Aldrich | ≥0.98 |
| Furazolidone | 67-45-8 | Sigma-Aldrich | ≥0.98 |
| 1-Octanol | 111-87-5 | Sigma-Aldrich | ≥0.99 |
| Potassium dihydrogen phosphate | 7778-77-0 | Merck | ≥0.99 |
| Disodium hydrogen phosphate dodecahydrate | 10039-32-4 | Merck | ≥0.99 |
| Potassium chloride | 7447-40-7 | Aldrich | ≥0.99 |
| Hydrochloric acid 0.1 mol·dm−3 fixanal | 7647-01-0 | Aldrich | - |
* as stated by the supplier.